+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID07767227

Pilot Study of miRNA and Protein Signatures in Blood and Cystic Fluid Exosomes from Patients Undergoing Surgery for Pancreatic Cysts

Led by Translational Genomics Research Institute · Updated on 2026-08-17

30

Participants Needed

2

Research Sites

13 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting an observational study to collect blood and cystic fluid samples from people who have pancreatic cysts that require surgical removal. The purpose is to analyze these samples for DNA, RNA, and proteins to better understand the characteristics of worrisome pancreatic cysts. This study is sponsored by the Translational Genomics Research Institute and aims to identify specific microRNA and protein patterns in exosomes from these fluids. Participants in this study are patients scheduled to undergo surgery to remove their pancreatic cysts as part of their usual medical care. The study collects biospecimens such as blood and cystic fluid at the time of surgery for analysis. No additional treatments or interventions are involved beyond the planned surgical procedure. While participating, patients will provide consent and allow collection of samples during their clinically indicated surgery. Researchers will examine the microRNA and protein signatures in the collected exosomes to gain insights into pancreatic cystic tumors. The study will continue until March 2028, with primary outcome measurements taken at enrollment during surgery.

CONDITIONS

Brief Title

Blood and Cystic Fluid From Patients Undergoing Surgery for Worrisome Pancreatic Cysts

Research Team

M

Michael Demeure, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here